(Q53076839)

11 May 2018

title

Molecular and Immunohistologic Analyses Cannot Reliably Solve Diagnostic Variation of Flat Intraepithelial Lesions of the Urinary Bladder (English)

1 reference

https://api.crossref.org/works/10.1309/AJCPACNUDWEN9GN4

29 August 2024

9

Toyonori Tsuzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21088148

29 August 2024

author name string

Shin-ichi Murata

1

1 reference

11 May 2018

Masachika Iseki

2

1 reference

11 May 2018

Mitsuru Kinjo

3

1 reference

11 May 2018

Osamu Matsuzaki

4

1 reference

11 May 2018

Akira Moriuchi

5

1 reference

11 May 2018

Hiroshi Ohtani

6

1 reference

11 May 2018

Takaki Sakurai

7

1 reference

11 May 2018

Tatsunari Satake

8

1 reference

11 May 2018

American Journal of Clinical Pathology

language of work or name

English

1 reference

inferred from

publication date

1 December 2010

1 reference

11 May 2018

full work available at URL

published in

American Journal of Clinical Pathology

1 reference

11 May 2018

volume

134

1 reference

11 May 2018

issue

6

1 reference

11 May 2018

page(s)

862-872

1 reference

11 May 2018

An approach to the diagnosis of flat intraepithelial lesions of the urinary bladder using the World Health Organization/ International Society of Urological Pathology consensus classification system

cites work

1 reference

https://api.crossref.org/works/10.1309%2FAJCPACNUDWEN9GN4

Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPACNUDWEN9GN4

High-molecular-weight cytokeratin antibody (clone 34betaE12) as a urothelial marker: a note of caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPACNUDWEN9GN4

Cytokeratin 20 and Ki-67 to distinguish carcinoma in situ from flat non-neoplastic urothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPACNUDWEN9GN4

p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPACNUDWEN9GN4

Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPACNUDWEN9GN4

Bladder cancer detection using FISH (UroVysion assay).

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPACNUDWEN9GN4

Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPACNUDWEN9GN4

Prognostic significance of nondiagnostic molecular changes in urine detected by UroVysion fluorescence in situ hybridization during surveillance for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPACNUDWEN9GN4

Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPACNUDWEN9GN4

Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPACNUDWEN9GN4

Flat intraepithelial lesions of the urinary bladder

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1309/AJCPACNUDWEN9GN4

Utility of cytokeratin 20 and Ki-67 as markers of urothelial dysplasia

29 August 2024

9

1 reference

https://api.crossref.org/works/10.1309/AJCPACNUDWEN9GN4

Expression of cytokeratin 20 in urine cytology smears: a potential marker for the detection of urothelial carcinoma

29 August 2024

12

1 reference

https://api.crossref.org/works/10.1309/AJCPACNUDWEN9GN4

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma

29 August 2024

14

1 reference

https://api.crossref.org/works/10.1309/AJCPACNUDWEN9GN4

Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings

29 August 2024

15

1 reference

https://api.crossref.org/works/10.1309/AJCPACNUDWEN9GN4

Conservation and alteration of chromosome territory arrangements in thyroid carcinoma cell nuclei

29 August 2024

20

1 reference

https://api.crossref.org/works/10.1309/AJCPACNUDWEN9GN4

p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma

29 August 2024

24

1 reference

https://api.crossref.org/works/10.1309/AJCPACNUDWEN9GN4

Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology

29 August 2024

25

1 reference

https://api.crossref.org/works/10.1309/AJCPACNUDWEN9GN4

29 August 2024

Identifiers

1 reference

11 May 2018

1 reference

11 May 2018